Friday, July 10, 2026

Drug profile · INN

diphtheria-tetanus-pertussis

diphtheria-tetanus-pertussis is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 0
Pipeline programs 2
News articles 0
Drug details — diphtheria-tetanus-pertussis
Class
Route
Patents
0
Programs
2
Data quality
0.70

Quick answer

diphtheria-tetanus-pertussis is an FDA-listed pharmaceutical active ingredient.

Key facts

INN diphtheria-tetanus-pertussis

Approval history

Authority Status Date
NMPA clinical trials

Pipeline programs

  1. diphtheria-tetanus-pertussis vaccine containing whole-cell pertussis Phase 3 · Ultragenyx UK · Pertussis
  2. VAN00013 Phase 2 · Sanofi-Aventis U.S · Meningococcal immunization

Frequently asked questions

What is diphtheria-tetanus-pertussis?

diphtheria-tetanus-pertussis is an FDA-listed pharmaceutical active ingredient.